Oldenburg B - Search Results

1

Chromogranin A regulates gut permeability via the antagonistic actions of its proteolytic peptides.

Muntjewerff EM, Tang K, Lutter L, Christoffersson G, Nicolasen MJT, Gao H, Katkar GD, Das S, Ter Beest M, Ying W, Ghosh P, El Aidy S, Oldenburg B, van den Bogaart G, Mahata SK. Muntjewerff EM, et al. Among authors: oldenburg b. Acta Physiol (Oxf). 2021 Jun;232(2):e13655. doi: 10.1111/apha.13655. Epub 2021 May 6. Acta Physiol (Oxf). 2021. PMID: 33783968 Free PMC article.

2

The elusive case of human intraepithelial T cells in gut homeostasis and inflammation.

Lutter L, Hoytema van Konijnenburg DP, Brand EC, Oldenburg B, van Wijk F. Lutter L, et al. Among authors: oldenburg b. Nat Rev Gastroenterol Hepatol. 2018 Oct;15(10):637-649. doi: 10.1038/s41575-018-0039-0. Nat Rev Gastroenterol Hepatol. 2018. PMID: 29973676 Review.

3

Homeostatic Function and Inflammatory Activation of Ileal CD8⁺ Tissue-Resident T Cells Is Dependent on Mucosal Location.

Lutter L, Roosenboom B, Brand EC, Ter Linde JJ, Oldenburg B, van Lochem EG, Horjus Talabur Horje CS, van Wijk F. Lutter L, et al. Among authors: oldenburg b. Cell Mol Gastroenterol Hepatol. 2021;12(5):1567-1581. doi: 10.1016/j.jcmgh.2021.06.022. Epub 2021 Jul 2. Cell Mol Gastroenterol Hepatol. 2021. PMID: 34224909 Free PMC article.

4

Compartment-driven imprinting of intestinal CD4 T cells in inflammatory bowel disease and homeostasis.

Lutter L, Ter Linde JJM, Brand EC, Hoytema van Konijnenburg DP, Roosenboom B, Horjus Talabur-Horje C, Oldenburg B, van Wijk F. Lutter L, et al. Among authors: oldenburg b. Clin Exp Immunol. 2023 Dec 13;214(3):235-248. doi: 10.1093/cei/uxad095. Clin Exp Immunol. 2023. PMID: 37565620 Free PMC article.

5

Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease.

Gadaleta RM, van Erpecum KJ, Oldenburg B, Willemsen EC, Renooij W, Murzilli S, Klomp LW, Siersema PD, Schipper ME, Danese S, Penna G, Laverny G, Adorini L, Moschetta A, van Mil SW. Gadaleta RM, et al. Among authors: oldenburg b. Gut. 2011 Apr;60(4):463-72. doi: 10.1136/gut.2010.212159. Epub 2011 Jan 17. Gut. 2011. PMID: 21242261

6

Farnesoid X receptor (FXR) activation and FXR genetic variation in inflammatory bowel disease.

Nijmeijer RM, Gadaleta RM, van Mil SW, van Bodegraven AA, Crusius JB, Dijkstra G, Hommes DW, de Jong DJ, Stokkers PC, Verspaget HW, Weersma RK, van der Woude CJ, Stapelbroek JM, Schipper ME, Wijmenga C, van Erpecum KJ, Oldenburg B; Dutch Initiative on Crohn, Colitis (ICC). Nijmeijer RM, et al. Among authors: oldenburg b. PLoS One. 2011;6(8):e23745. doi: 10.1371/journal.pone.0023745. Epub 2011 Aug 22. PLoS One. 2011. PMID: 21887309 Free PMC article.

7

Signal Inhibitory Receptor on Leukocytes-1 is highly expressed on lung monocytes, but absent on mononuclear phagocytes in skin and colon.

von Richthofen HJ, Gollnast D, van Capel TMM, Giovannone B, Westerlaken GHA, Lutter L, Oldenburg B, Hijnen D, van der Vlist M, de Jong EC, Meyaard L. von Richthofen HJ, et al. Among authors: oldenburg b. Cell Immunol. 2020 Nov;357:104199. doi: 10.1016/j.cellimm.2020.104199. Epub 2020 Aug 28. Cell Immunol. 2020. PMID: 32942189 Free article.

8

Patients Prioritize a Low-volume Bowel Preparation in Colitis-associated Colorectal Cancer Surveillance: A Discrete Choice Experiment.

Wijnands AM, Te Groen M, Peters Y, Kaptein AA, Oldenburg B, Hoentjen F, Lutgens MWMD. Wijnands AM, et al. Among authors: oldenburg b. Inflamm Bowel Dis. 2022 Jul 1;28(7):1053-1060. doi: 10.1093/ibd/izab221. Inflamm Bowel Dis. 2022. PMID: 34487155 Free PMC article.

9

Editorial: risk of loss of response to anti TNFα in patients with inflammatory bowel diseases - the longer the less? Authors' reply.

Schultheiss JPD, Mahmoud R, Fidder HH, Oldenburg B. Schultheiss JPD, et al. Among authors: oldenburg b. Aliment Pharmacol Ther. 2022 Jan;55(2):246. doi: 10.1111/apt.16722. Aliment Pharmacol Ther. 2022. PMID: 34970765 No abstract available.

10

Letter: loss of response to anti-TNFα agents depends on treatment duration in patients with inflammatory bowel disease-authors' reply.

Mahmoud R, Schultheiss JPD, Fidder HH, Oldenburg B. Mahmoud R, et al. Among authors: oldenburg b. Aliment Pharmacol Ther. 2022 Feb;55(4):499-500. doi: 10.1111/apt.16757. Aliment Pharmacol Ther. 2022. PMID: 35092052 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

568 results

Search Page

Filters